scholarly journals Comparative Analysis of the Informative Value of Radioimmunoassay and Laser Correlation Spectroscopy in Myasthenia Gravis

2014 ◽  
Vol 2014 ◽  
pp. 1-5
Author(s):  
Irina Alchinova ◽  
Elena Arkhipova ◽  
Dmitry Sidnev ◽  
Alexandr Sanadze ◽  
Sergey Dedaev ◽  
...  

The objective of this study was to compare informative value of traditional approach (anti-AChR antibody radioimmunoassay) and evaluation of metabolic shifts by laser correlation spectroscopy in myasthenia gravis. The method based on changes in spectral characteristics of laser radiation caused by scattering in a disperse system yields a histogram reflecting particle contribution into light scatter as a function of particle radius in nanometers. The spectrum of anti-AChR-positive serum is characterized by appreciably increased contribution of particles with a radius 4.6–6.2 nm. Binding of serum components with solubilized AChR confirms that this peak is determined by elevated concentration of antibodies to this receptor. The search for the relationship between the disease severity and the distribution pattern of subfraction serum components revealed three informative zones: 6–15, 27–67, and 127–223 nm. In patients without disturbances of vital functions, the contribution of the first zone particles into light scatter increases and that of the third zone particles decreases. Considerable differences attaining the level of statistical significance in zones 4–6 and 20 nm were revealed in the spectra of serum from patients with myasthenia gravis of the same severity with and without thymoma. This opens prospects for dynamic monitoring of the efficiency of therapy.

Author(s):  
Kuan Chen ◽  
James Cheng-Chung Wei ◽  
Hei-Tung Yip ◽  
Mei-Chia Chou ◽  
Renin Chang

Mycoplasma pneumoniae (M. pneumoniae) is not only one of the most common pathogenic bacteria for respiratory infection but also a trigger for many autoimmune diseases. Its infection process shared many similarities with the pathogenesis of myasthenia gravis (MG) at cellular and cytokine levels. Recent case reports demonstrated patients present with MG after M. pneumoniae infection. However, no epidemiological studies ever looked into the association between the two. Our study aimed to investigate the relationship between M. pneumoniae infection and subsequent development of MG. In this population-based retrospective cohort study, the risk of MG was analyzed in patients who were newly diagnosed with M. pneumoniae infection between 2000 and 2013. A total of 2428 M. pneumoniae patients were included and matched with the non-M. pneumoniae control cohort at a 1:4 ratio by age, sex, and index date. Cox proportional hazards regression analysis was applied to analyze the risk of MG development after adjusting for sex, age, and comorbidities, with hazard ratios and 95% confidence intervals. The incidence rates of MG in the non-M. pneumoniae and M. pneumoniae cohorts were 0.96 and 1.97 per 10,000 person-years, respectively. Another case–control study of patients with MG (n = 515) was conducted to analyze the impact of M. pneumoniae on MG occurrence as a sensitivity analysis. The analysis yielded consistent absence of a link between M. pneumoniae and MG. Although previous studies have reported that M. pneumoniae infection and MG may share associated immunologic pathways, we found no statistical significance between M. pneumoniae infection and subsequent development of MG in this study.


2003 ◽  
Author(s):  
Alexander N. Korolevich ◽  
N. P. Prigun ◽  
A. Y. Khairullina ◽  
M. S. Belsley

1995 ◽  
Vol 119 (5) ◽  
pp. 539-542 ◽  
Author(s):  
A. V. Akleev ◽  
I. A. Pashkov ◽  
N. V. Klopov ◽  
A. D. Lebedev ◽  
A. G. Silina ◽  
...  

1979 ◽  
Vol 301 (12) ◽  
pp. 625-629 ◽  
Author(s):  
Abraham Shore ◽  
Sukanya Limatibul ◽  
Hans-Michael Dosch ◽  
Erwin W. Gelfand

2017 ◽  
Author(s):  
Elina Nepomnyashchaya ◽  
Ekaterina Savchenko ◽  
Elena Velichko ◽  
Evgenij Aksenov

1991 ◽  
Vol 111 (3) ◽  
pp. 320-323
Author(s):  
V. S. Lobzin ◽  
I. I. Nisevich ◽  
V. S. Omel'chenko ◽  
A. G. Silina ◽  
A. M. Stepanov ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document